24 research outputs found

    Dose-Response Relationships Following Oral Administration of DuP 753 to Normal Humans

    Get PDF
    We assessed the inhibitory effect of DuP 753, an orally active angiotensin II receptor antagonist, on the pressor action of exogenous angiotensin I and II in healthy volunteers. In a single dose study, doses of 2.5, 5, 10, 20, and 40 mg of DuP 753 or placebo were tested serially at one week intervals. In the multiple dose study, the administration of placebo or DuP 753 (5, 10, 20, or 40 mg, per os once daily) for eight consecutive days was evaluated. The blood pressure response to angiotensin I and II was inhibited in a dose-dependent fashion with a blocking effect still present 24 h post drug. DuP 753 also induced a dose-dependent compensatory rise in plasma renin. This new compound was well tolerated by these normal volunteers. Thus, DuP 753 appears to be a well tolerated, orally active, potent and long-lasting antagonist of angiotensin II in humans. Am J Hypertens 1991;4:350S-354

    Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.

    No full text
    Blood pressures measured casually by a doctor often differ considerably from those recorded during everyday activities away from the medical environment. In the present study, we compared office and ambulatory recorded pressures in 475 consecutive untreated patients diagnosed hypertensive by physicians. Blood pressure monitored non-invasively during the day was, on average 15/7 mmHg lower than the corresponding office pressures. The difference between office and ambulatory recorded pressure tended to be greatest in those patients with the highest office blood pressure levels, although the relationship between the two types of measurement was too weak (r = 0.50 and 0.38 for systolic and diastolic pressure, respectively) to have any predictive value in the individual patient. Office blood pressures were at least 10 mmHg higher than ambulatory pressures in 62% of patients for systolic and 42% for diastolic pressure. Blood pressure levels recorded during ambulatory monitoring were higher than in the doctor's office for 18% of patients for systolic and 22% for diastolic pressure. Among patients with systolic pressures of between 161 and 180 mmHg or diastolic pressures between 96 and 105 mmHg when facing a doctor, 27 and 37% respectively, showed markedly lower systolic (less than 140 mmHg) or diastolic (less than 90 mmHg) ambulatory recorded pressures. These data therefore indicate that ambulatory blood pressure monitoring may help to identify those truly hypertensive patients who are most likely to benefit from antihypertensive therapy

    Properties of aligned YBa2Cu3O7−δ superconductor as a function of oxygen deficiency δ

    No full text
    Ossandon, J.G. Department of Engineering Sciences, Universidad de Talca, Curicó, Chile.Systematic studies of flux pinning and intragrain critical current Jc were conducted in magnetically aligned, sintered Y1Ba2Cu3O7−δ material as a function of oxygen deficiency δ in the range 0 ˜ 0.2. The essential findings are: 1. (1) maximum Jc occurred at full oxygenation, i.e., Jc and pinning decreased steadily as oxygen was removed; 2. (2) the irreversibility line Birr(T, δ) was degraded with the introduction of oxygen defects; 3. (3) this degradation was strongly correlated with the reduction of Jc(δ), implying that the irreversibility line is determined by the strength of the flux pinning defects; 4. (4) the condensation energy Fc decreased significantly with δ, indicating a rapid weakening in the effectiveness of pre-existing pinning centers; 5. (5) both λ and ξ increased as oxygen was removed, while 6. (6) their ratio κ and the superconductive anisotropy parameter γ = (λc/λab) ≈ 5 varied little for

    Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.

    No full text
    The aim of this study was to investigate the relationships between plasma concentrations of losartan, an orally active angiotensin II inhibitor, its active metabolite EXP3174, and angiotensin II blockade. Six healthy subjects received single oral doses of 40, 80, or 120 mg losartan and placebo at 1-week intervals in a crossover study. Angiotensin II blockade was assessed by the blood pressure response to exogenous angiotensin II before and after losartan administration. EXP3174 reached higher plasma concentrations and was eliminated more slowly than its parent compound; its levels paralleled the profile of angiotensin II blockade closer than losartan. Inhibition of the pressure response was dose dependent. The Hill-shaped relationship between response and EXP3174 concentration (or time-integrated variables) approached a plateau with 80 mg. The dose-dependent increase in plasma renin and angiotensin II exhibited a considerable individual scatter. We conclude that losartan produces a dose-dependent, effective angiotensin II blockade that is largely determined by the active metabolite EXP3174
    corecore